News for 'Intellectual Property Rights'

Wadias, Danone to revive talks

Wadias, Danone to revive talks

Rediff.com7 Mar 2007

The warring promoters of FMCG major Britannia - the Wadias and the French dairy giant Danone - are looking at sorting out intellectual property rights issues

India an innovation giant? Yes!

India an innovation giant? Yes!

Rediff.com21 Feb 2007

The country has the opportunity of creating new business models, products and services for the poor not just at home, but for countries in Africa and Latin America.

Patent law: What the fine print says

Patent law: What the fine print says

Rediff.com30 Dec 2004

Let's look at the major provisions that will have lasting effect on the industry, both domestic and exports.

What Are MNC Funds?

What Are MNC Funds?

Rediff.com28 Oct 2024

MNC funds invest in companies where foreign promoters have more than 50 per cent shareholding.

Artists must demand their resale rights

Artists must demand their resale rights

Rediff.com13 May 2009

India's Copyright Act allows for a percentage of any secondary art sale to be paid to the original copyright holder.

Mahindra to make India's own Humvee

Mahindra to make India's own Humvee

Rediff.com31 Mar 2021

Mahindra's LSV is an extremely agile combat vehicle with all round protection against small arms fire.

India, UK to work on Trips impasse

India, UK to work on Trips impasse

Rediff.com8 Jan 2003

Jet to pay $ 7.5 mn for IPRs

Jet to pay $ 7.5 mn for IPRs

Rediff.com17 Feb 2005

A day before the opening of its initial public offering, Jet Airways on Thursday said it will pay up to $7.5 million to acquire trademark and intellectual property rights from Naresh Goyal-promoted Jet Enterprises Private Ltd.

The Dangerous Reality Behind Maharashtra's 'Urban Naxal' Law

The Dangerous Reality Behind Maharashtra's 'Urban Naxal' Law

Rediff.com21 Aug 2025

'The law under the guise of security represents a grave and unnecessary expansion of State power at the cost of fundamental rights,' asserts Aakar Patel.

Indian pharma's Trump fears

Indian pharma's Trump fears

Rediff.com1 Feb 2017

Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports.

US seeks to step up trade talks with India after WTO breakthrough

US seeks to step up trade talks with India after WTO breakthrough

Rediff.com24 Nov 2014

Direct contacts between Obama and Prime Minister Narendra Modi this month helped to end a deadlock that had prevented the WTO from implementing a $1 trillion package of reforms.

'Modi doing the right thing': Putin praises 'Make in India'

'Modi doing the right thing': Putin praises 'Make in India'

Rediff.com13 Sep 2023

Putin made these remarks on Tuesday while speaking at the Plenary session of the 8th Eastern Economic Forum in Vladivostok, a major port city in sanctions-hit Russia's Far East region

India to take on US if labelled 'poor' in IPR laws

India to take on US if labelled 'poor' in IPR laws

Rediff.com28 Apr 2014

Adverse IPR report expected this week;Poor labelling could take fight to WTO

Novartis sues Biocon for patent breach

Novartis sues Biocon for patent breach

Rediff.com4 Apr 2014

The multinational has filed infringement proceedings and is seeking an injunction against the Indian rival at the Delhi High Court, trying to block the Bangalore-based biotechnology firm from launching a generic version of Galvus, also known as vildagliptin.

'Mahindra Electric Is Getting Free Publicity'

'Mahindra Electric Is Getting Free Publicity'

Rediff.com9 Dec 2024

'IndiGo's position in this argument will depend on whether it has registered '6e' as a trademark.'

The Big Change At Karan Johar's Dharma

The Big Change At Karan Johar's Dharma

Rediff.com22 Oct 2024

Industry experts believe that this deal will positively impact the Indian film industry, which is struggling with fewer movie releases.

Banganapalle mango gets GI tagged to Andhra

Banganapalle mango gets GI tagged to Andhra

Rediff.com4 May 2017

The Andhra Pradesh government is now the registered proprietor of the GI tag for the mango variety often hailed as "the king of fruits".

Infy founder's son to launch E2W at Bharat Mobility

Infy founder's son to launch E2W at Bharat Mobility

Rediff.com14 Jan 2025

Numeros Motors is also planning to come up with a passenger vehicle four-wheeler or a three-wheeler by 2027.

Sun Pharma sues Novartis in US court

Sun Pharma sues Novartis in US court

Rediff.com13 Jun 2013

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.

Indian govt prepares to battle US pressure on trade laws

Indian govt prepares to battle US pressure on trade laws

Rediff.com22 Apr 2014

A certain segment of the US pharma industry have become vocal about Indian policies on domestic content requirements and IPR.

Not facing any significant IPR challenges in India: Abbott

Not facing any significant IPR challenges in India: Abbott

Rediff.com25 Apr 2014

In 2010, Abbott acquired both the pharmaceutical business of Solvay, which had a presence in India, and Piramal Healthcare Solutions, which was part of Piramal Group.

India, US eyeing to ink 5 pacts during Trump's visit

India, US eyeing to ink 5 pacts during Trump's visit

Rediff.com21 Feb 2020

Ahead of his India visit on February 24-25, Trump said that India has not treated his country 'very well' on the trade front and indicated that a 'very big' bilateral deal with New Delhi may not be signed before the American presidential election in November.

Snapdeal, 4 Indian shopping complexes in US Notorious Markets list

Snapdeal, 4 Indian shopping complexes in US Notorious Markets list

Rediff.com29 Apr 2020

Other than Snapdeal, the four markets are Tank Road in Delhi, Heera Panna in Mumbai, Kidderpore in Kolkata and Millennium Centre in Aizawl. Snapdeal, one of India's largest e-commerce platforms, is known as a place to purchase counterfeit watches and shoes.

For 'Make in India', first 'Innovate in India'

For 'Make in India', first 'Innovate in India'

Rediff.com7 May 2015

The 'Make in India' vision cannot survive in the long-term without concrete measures to build a concurrent 'Create in India' movement.

IP environment deteriorating in India: US pharma industry

IP environment deteriorating in India: US pharma industry

Rediff.com2 Jul 2013

The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.

India gets an earful from US on affordable healthcare issues

India gets an earful from US on affordable healthcare issues

Rediff.com26 Nov 2014

US said access to affordable health care entails a large number of factors from rates, logistics to insurance reforms.

'India has a vital stake in the digital renaissance'

'India has a vital stake in the digital renaissance'

Rediff.com5 Jun 2015

'Everywhere our younger computer professionals are in the forefront, defending our national interest in every forum and keeping our flag flying high.'

Sensex rallies 272 points on gains in auto, IT stocks

Sensex rallies 272 points on gains in auto, IT stocks

Rediff.com6 May 2021

On the Sensex chart, Bajaj Auto, HDFC, Infosys, Tech Mahindra and ICICI bank emerged as the prominent gainers. NSE Nifty ended with a gain of 106.95 points at 14,724.80.

India must act fast to frame new IPR policy

India must act fast to frame new IPR policy

Rediff.com24 Nov 2014

India had been engaged in a contentious battle with the US over the issue, especially in the pharmaceutical sector.

Reliance Has Filed 3,000 Plus Patents

Reliance Has Filed 3,000 Plus Patents

Rediff.com25 Oct 2024

Reliance has filed patents not only in India but also in the US, Canada, Europe, Estonia, South Korea, and South America. The patents include narrowband Internet of Things, AI large language models, AI DeepLearning, Big Data, devices, and quantum AI in 6G.

New competition law likely to open up settlement route for cartels

New competition law likely to open up settlement route for cartels

Rediff.com30 Jan 2023

In a relief to industry, the government has accepted a parliamentary panel's recommendation on allowing cartels to opt for the settlement scheme under the Competition Amendment Bill, according to official sources. The proposed Bill seeks to introduce a clause for settlement and commitment that offers any enterprise against which an inquiry has been initiated to file an application for settlement. The Parliamentary Committee on Finance had suggested including cartels in the scope for settlement "as a pragmatic recourse to the whole process".

'AI Doesn't Care Where It Goes To School'

'AI Doesn't Care Where It Goes To School'

Rediff.com25 Oct 2024

'No one manufactures intelligence at the moment.' 'This is a concept that your IT industry understands.' 'What you need is infrastructure. Everything else can then be taken care of.'

Sitharaman to attend G-20 meet in Rome

Sitharaman to attend G-20 meet in Rome

Rediff.com28 Oct 2021

Finance Minister Nirmala Sitharaman will attend the G-20 joint finance and health ministers' meeting in Rome on October 29, which among other things will discuss COVID pandemic prevention and response. "Union Finance Minister Smt. @nsitharaman embarks on an official visit to attend #G20 Joint Finance & Health Ministers meeting in #Rome to discuss measures to strengthen #COVID19 #PandemicPrevention, #preparedness & #response. The meeting precedes #G20RomeSummit," the Finance Ministry tweeted. Finance and health ministers will discuss how to keep momentum in response to the pandemic and build on further coordination arrangements between the ministries.

After 15 years, Ranjit Shahani steps down as Novartis' India chief

After 15 years, Ranjit Shahani steps down as Novartis' India chief

Rediff.com14 Nov 2017

The face of MNC drug firms in India and champion of IPR protection, he oversaw the Swiss giant's India expansion, its forays into new therapies and setting up of its global service centre in Hyderabad

Ex-IAS Rajiv Aggarwal succeeds Ankhi Das as FB India policy head

Ex-IAS Rajiv Aggarwal succeeds Ankhi Das as FB India policy head

Rediff.com20 Sep 2021

Aggarwal, in this role, will define and lead important policy development initiatives for Facebook in India on an agenda that covers user safety, data protection and privacy, inclusion and internet governance, a statement said.

'Copyright piracy has reached alarming level in China, India'

'Copyright piracy has reached alarming level in China, India'

Rediff.com26 Jun 2014

The report '2014 International Piracy Watch List,' by International Creativity and Theft-Prevention Caucus highlights the high levels of piracy and the lack of legal protections for copyright in China, Russia, Switzerland and India.

Brain Drain 2.0 Is Taking Place In India

Brain Drain 2.0 Is Taking Place In India

Rediff.com28 Sep 2023

The migration of domestically developed intellectual property to foreign corporations within India reflects an anomaly in the demand pattern of the country's job market, points out Kanika Datta.